Navigation Links
Hospital to Hold MRSA Briefing for Media and Community Leaders
Date:10/30/2007

Dr. James Rahal, Infectious Disease Specialist, also available as Expert Resource

FLUSHING, N.Y., Oct. 30 /PRNewswire-USNewswire/ -- The following is being issued by New York Hospital Queens:

WHAT: A special briefing on methicillin-resistant Staphylococcus

aureus(MRSA) is scheduled for media and community leaders.

James Rahal, M.D., and a team of infectious disease

specialists from New York Hospital Queens will address the

basis of concern about this infection. They will discuss the

risks, and address the fear caused by recent cases of

community-acquired MRSA infection in the New York area.

During the briefing, the date and location of a community

education program is expected to be announced.

WHEN: Thursday, November 1, 2007 at 10 a.m.

WHERE: New York Hospital Queens 56-45 Main Street, Flushing NY

11355

Lang Auditorium (please leave 15 minutes for access from

parking area)

FYI: Methicillin-resistant Staphylococcus aureus (MRSA) is a type

of Staph that is resistant to commonly used antibiotics. MRSA

infections occur most frequently among persons in hospitals

and healthcare facilities (such as nursing homes and dialysis

centers) who have weakened immune systems.

MRSA infections that are acquired by healthy persons in the

community who have not been recently (within the past year)

hospitalized or had a medical procedure are known as

Community Acquired-MRSA infections (CA-MRSA). These CA-MRSA

infections are usually manifested as skin infections, such as

pimples, boils, or abscesses; and rarely, pneumonia. For

background on healthcare and community-acquired infections,

as well as infection control guidance, including in school

settings, go to http://www.cdc.gov/ncidod.

NYHQ conducts ongoing surveillance for infectious diseases,

as well as targeted research. An original article based upon

a multi-year investigation into the impact on MRSA is being

published in the November issue of the journal Infection

Control and Hospital Epidemiology.

CONTACT: Cynthia Bacon

(718) 670-2515


'/>"/>
SOURCE New York Hospital Queens
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
6. Six Important Things to Know About Preventing Hospital Infections
7. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
8. Hospitalization Rates for Coronary Artery Disease Decline in the U.S.
9. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
10. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
11. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Tenn. , March 23, 2017  Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... announced Definitive Financing Commitment Term Sheet (the "Definitive ... a group of the Company,s stockholders, who are ... Group" in a Form 8-K filed with the ...
(Date:3/23/2017)... 23, 2017 The key factors driving ... diabetic population, accelerating economic growth and increasing healthcare expenditure. Some ... higher life expectancy of ESRD patients, rising demand for home ... the expansion of the market is hindered by high treatment ... ...
(Date:3/23/2017)... 23, 2017 As a result of ... the prevalence of allergic diseases, cutting edge developments ... revolutionising the ways in which pharmaceutical and biotech ... promises to be both a high quality meeting ... interest groups, immunologists, research scholars and doctors. The ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... ... Digital Scientists, a software innovation lab specializing in web design and ... Carolina location. The lab has set up shop at the renowned NEXT Innovation ... Carolina clients for years from our office here in Atlanta,” explains Digital Scientists’ CEO, ...
(Date:3/24/2017)... Lake Orion, MI (PRWEB) , ... March 24, ... ... providing insurance assistance, financial planning, and related services to families and business owners ... charity initiative aimed at feeding regional families struggling with financial difficulties. , The ...
(Date:3/24/2017)... CA (PRWEB) , ... March 24, 2017 , ... ... on two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, ... Creating the Administrative Record, The majority of cases litigated under ERISA involve claims ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
Breaking Medicine News(10 mins):